BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12532422)

  • 1. Serologic analysis of ovarian tumor antigens reveals a bias toward antigens encoded on 17q.
    Stone B; Schummer M; Paley PJ; Thompson L; Stewart J; Ford M; Crawford M; Urban N; O'Briant K; Nelson BH
    Int J Cancer; 2003 Mar; 104(1):73-84. PubMed ID: 12532422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomic analysis of human sarcoma.
    Lee SY; Obata Y; Yoshida M; Stockert E; Williamson B; Jungbluth AA; Chen YT; Old LJ; Scanlan MJ
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2651-6. PubMed ID: 12601173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology.
    Mok SC; Chao J; Skates S; Wong K; Yiu GK; Muto MG; Berkowitz RS; Cramer DW
    J Natl Cancer Inst; 2001 Oct; 93(19):1458-64. PubMed ID: 11584061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.
    Odunsi K; Jungbluth AA; Stockert E; Qian F; Gnjatic S; Tammela J; Intengan M; Beck A; Keitz B; Santiago D; Williamson B; Scanlan MJ; Ritter G; Chen YT; Driscoll D; Sood A; Lele S; Old LJ
    Cancer Res; 2003 Sep; 63(18):6076-83. PubMed ID: 14522938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cloning of a novel human gene on chromosome 4p11 by immunoscreening of an ovarian carcinoma cDNA library.
    Luo LY; Soosaipillai A; Diamandis EP
    Biochem Biophys Res Commun; 2001 Jan; 280(1):401-6. PubMed ID: 11162530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression.
    Scanlan MJ; Gout I; Gordon CM; Williamson B; Stockert E; Gure AO; Jäger D; Chen YT; Mackay A; O'Hare MJ; Old LJ
    Cancer Immun; 2001 Mar; 1():4. PubMed ID: 12747765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel cancer/testis antigen KP-OVA-52 identified by SEREX in human ovarian cancer is regulated by DNA methylation.
    Kim KM; Song MH; Kim MJ; Daudi S; Miliotto A; Old L; Odunsi K; Lee SY
    Int J Oncol; 2012 Sep; 41(3):1139-47. PubMed ID: 22684412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigens recognized by autologous antibody in patients with renal-cell carcinoma.
    Scanlan MJ; Gordan JD; Williamson B; Stockert E; Bander NH; Jongeneel V; Gure AO; Jäger D; Jäger E; Knuth A; Chen YT; Old LJ
    Int J Cancer; 1999 Nov; 83(4):456-64. PubMed ID: 10508479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor associated antigen recognition by autologous serum in patients with breast cancer.
    Qian F; Odunsi K; Blatt LM; Scanlan MJ; Mannan M; Shah N; Montgomery J; Haddad F; Taylor M
    Int J Mol Med; 2005 Jan; 15(1):137-44. PubMed ID: 15583840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the novel serum markers B7-H4, Spondin 2, and DcR3 for diagnosis and early detection of ovarian cancer.
    Simon I; Liu Y; Krall KL; Urban N; Wolfert RL; Kim NW; McIntosh MW
    Gynecol Oncol; 2007 Jul; 106(1):112-8. PubMed ID: 17490732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The construction of cDNA library and the screening of related antigen of ascitic tumor cells of ovarian cancer.
    Hou Q; Chen K; Shan Z
    Eur J Gynaecol Oncol; 2015; 36(5):590-4. PubMed ID: 26513889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a combination of approaches to identify and validate relevant tumor-associated antigens and their corresponding autoantibodies in ovarian cancer patients.
    Gagnon A; Kim JH; Schorge JO; Ye B; Liu B; Hasselblatt K; Welch WR; Bandera CA; Mok SC
    Clin Cancer Res; 2008 Feb; 14(3):764-71. PubMed ID: 18245537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral immune responses against tumor-associated antigen OVA66 originally defined by serological analysis of recombinant cDNA expression libraries and its potentiality in cellular immunity.
    Jin S; Wang Y; Zhang Y; Zhang HZ; Wang SJ; Tang JQ; Chen HJ; Ge HL
    Cancer Sci; 2008 Aug; 99(8):1670-8. PubMed ID: 18754882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum.
    Jäger D; Unkelbach M; Frei C; Bert F; Scanlan MJ; Jäger E; Old LJ; Chen YT; Knuth A
    Cancer Immun; 2002 Jun; 2():5. PubMed ID: 12747750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of BCP-20 (FBXO39) as a cancer/testis antigen from colon cancer patients by SEREX.
    Song MH; Ha JC; Lee SM; Park YM; Lee SY
    Biochem Biophys Res Commun; 2011 May; 408(2):195-201. PubMed ID: 21338577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Human esophageal carcinoma antigens screened by serologic analysis of recombinant cDNA expression libraries (SEREX)].
    Yu L; Hu H; Ran YL; Peng LP; Li JW; Yang ZH
    Ai Zheng; 2007 Jan; 26(1):100-5. PubMed ID: 17222377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum autoantibodies against a panel of 15 tumor-associated antigens in the detection of ovarian cancer.
    Sun H; Shi JX; Zhang HF; Xing MT; Li P; Dai LP; Luo CL; Wang X; Wang P; Ye H; Li LX; Zhang JY
    Tumour Biol; 2017 Jun; 39(6):1010428317699132. PubMed ID: 28618923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer/testis antigen CT45: analysis of mRNA and protein expression in human cancer.
    Chen YT; Hsu M; Lee P; Shin SJ; Mhawech-Fauceglia P; Odunsi K; Altorki NK; Song CJ; Jin BQ; Simpson AJ; Old LJ
    Int J Cancer; 2009 Jun; 124(12):2893-8. PubMed ID: 19296537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
    Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A
    Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of paraneoplastic antigens reveals TRIM21 autoantibodies as biomarker for early detection of ovarian cancer in combination with autoantibodies to NY-ESO-1 and TP53.
    Hurley LC; Levin NK; Chatterjee M; Coles J; Muszkat S; Howarth Z; Dyson G; Tainsky MA
    Cancer Biomark; 2020; 27(3):407-421. PubMed ID: 32083570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.